Compare $AQB vs $CELZ | Chartloom

Compare

$AQB vs $CELZ

AquaBounty Technologies Inc · Creative Medical Technology Holdings Inc

AQB

AquaBounty Technologies Inc

CELZ

Creative Medical Technology Holdings Inc

Compare $AQB vs $CELZ

Comparing AquaBounty Technologies Inc and Creative Medical Technology Holdings Inc

AQBAquaBounty Technologies Inc

CELZCreative Medical Technology Holdings Inc

AQBAquaBounty Technologies Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

10.5%

52W performance

-47.5%

FCF yield

-132.7%

CELZCreative Medical Technology Holdings Inc

Market cap

$4M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-50.0%

YTD performance

-57.4%

52W performance

-76.5%

FCF yield

-148.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AQB

CELZ

Detailed metrics comparison

AQB

AquaBounty Technologies Inc

CELZ

Creative Medical Technology Holdings Inc

Market Cap

AQB$5M

CELZ$4M

Enterprise Value

AQB$4M

CELZ$-5M

Price

AQB$1.05

CELZ$0.84

P/E Ratio

AQBN/A

CELZN/A

P/S Ratio

AQB3.78x

CELZ1,324.83x

EV/Sales

AQB2.28x

CELZ-1,579.87x

EV/EBITDA

AQB0.00x

CELZ0.00x

P/B Ratio

AQB1.69x

CELZ0.72x

P/FCF Ratio

AQBN/A

CELZN/A

EV/FCF

AQB-0.49x

CELZ0.80x

PEG Ratio

AQBN/A

CELZN/A

Forward P/E (NTM)

AQBN/A

CELZN/A

Forward P/S (NTM)

AQBN/A

CELZN/A

Revenue (TTM)

AQB$0

CELZ$3K

Revenue Growth (YoY)

AQB-100.0%

CELZ-50.0%

Forward Rev Growth

AQB0.0%

CELZ56.2%

Gross Margin (TTM)

AQB0.0%

CELZ66.7%

Operating Margin (TTM)

AQB0.0%

CELZ0.0%

EBITDA Margin (TTM)

AQB0.0%

CELZ-204213.3%

Net Margin (TTM)

AQB0.0%

CELZ-201356.7%

FCF Margin (TTM)

AQBN/A

CELZ-196726.7%

Net Income (TTM)

AQB$-18M

CELZ$-6M

FCF (TTM)

AQB$-7M

CELZ$-6M

EPS (TTM)

AQB-$3.56

CELZ-$1.63

ROE (TTM)

AQB-4002.0%

CELZ-8670.0%

ROA (TTM)

AQB-12997.0%

CELZ-8196.0%

ROIC (TTM)

AQB-2623.0%

CELZ-8670.0%

Cash

AQB$2M

CELZ$9M

Debt

AQB$0

CELZ$0

Net Cash/Debt

AQB$2M

CELZ$9M

Current Ratio (TTM)

AQB4.26x

CELZ12.91x

Quick Ratio (TTM)

AQB4.22x

CELZ12.63x

Debt/Equity (TTM)

AQB0.21x

CELZ0.00x

Debt/Assets (TTM)

AQB0.0%

CELZ0.0%

Interest Coverage (TTM)

AQBN/A

CELZN/A

Net Debt/EBITDA (TTM)

AQB0.00x

CELZ0.00x

Beta

AQB1.45

CELZ1.93

52W Performance

AQB-47.5%

CELZ-76.5%

YTD Performance

AQB10.5%

CELZ-57.4%

% from 52W High

AQB-48.5%

CELZ-86.6%

% from 52W Low

AQB35.6%

CELZ35.2%

Asset Turnover (TTM)

AQB0.01x

CELZ0.00x

FCF Yield (TTM)

AQB-132.7%

CELZ-148.5%

Earnings Yield (TTM)

AQB-339.3%

CELZ-152.0%

Dividend Yield (TTM)

AQBN/A

CELZN/A

Rule of 40

AQB-100.0

CELZ-196,776.7

EV/GP/RG

AQBN/A

CELZN/A

Ticker research

View AQB research View CELZ research

Metric	AQB AquaBounty Technologies Inc	CELZ Creative Medical Technology Holdings Inc
Market & Valuation
Market Cap	$5M	$4M
Enterprise Value	$4M	$-5M
Price	$1.05	$0.84
P/E Ratio	N/A	N/A
P/S Ratio	3.78x	1,324.83x
EV/Sales	2.28x	-1,579.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.69x	0.72x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.49x	0.80x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$3K
Revenue Growth (YoY)	-100.0%	-50.0%
Forward Rev Growth	0.0%	56.2%
Profitability
Gross Margin (TTM)	0.0%	66.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-204213.3%
Net Margin (TTM)	0.0%	-201356.7%
FCF Margin (TTM)	N/A	-196726.7%
Net Income (TTM)	$-18M	$-6M
FCF (TTM)	$-7M	$-6M
EPS (TTM)	-$3.56	-$1.63
ROE (TTM)	-4002.0%	-8670.0%
ROA (TTM)	-12997.0%	-8196.0%
ROIC (TTM)	-2623.0%	-8670.0%
Financial Health
Cash	$2M	$9M
Debt	$0	$0
Net Cash/Debt	$2M	$9M
Current Ratio (TTM)	4.26x	12.91x
Quick Ratio (TTM)	4.22x	12.63x
Debt/Equity (TTM)	0.21x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	1.93
52W Performance	-47.5%	-76.5%
YTD Performance	10.5%	-57.4%
% from 52W High	-48.5%	-86.6%
% from 52W Low	35.6%	35.2%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-132.7%	-148.5%
Earnings Yield (TTM)	-339.3%	-152.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-196,776.7
EV/GP/RG	N/A	N/A
Ticker research	View AQB research	View CELZ research

Valuation

P/S Ratio

AQB

3.78x

CELZ

1,324.83x

EV/FCF

AQB

-0.49x

CELZ

0.80x

Growth & revenue

Revenue Growth TTM

CELZ

-50.0%

AQB

-100.0%

Forward Revenue Growth

CELZ

56.2%

AQB

0.0%

Profitability & performance

Gross Margin

CELZ

66.7%

AQB

0.0%

ROE

AQB

-4002.0%

CELZ

-8670.0%

FCF Yield %

AQB

-132.7%

CELZ

-148.5%

52-Week Performance

AQB

-47.5%

CELZ

-76.5%

Detailed metrics comparison

AQB

AquaBounty Technologies Inc

CELZ

Creative Medical Technology Holdings Inc

Market Cap

AQB$5M

CELZ$4M

Enterprise Value

AQB$4M

CELZ$-5M

Price

AQB$1.05

CELZ$0.84

P/E Ratio

AQBN/A

CELZN/A

P/S Ratio

AQB3.78x

CELZ1,324.83x

EV/Sales

AQB2.28x

CELZ-1,579.87x

EV/EBITDA

AQB0.00x

CELZ0.00x

P/B Ratio

AQB1.69x

CELZ0.72x

P/FCF Ratio

AQBN/A

CELZN/A

EV/FCF

AQB-0.49x

CELZ0.80x

PEG Ratio

AQBN/A

CELZN/A

Forward P/E (NTM)

AQBN/A

CELZN/A

Forward P/S (NTM)

AQBN/A

CELZN/A

Revenue (TTM)

AQB$0

CELZ$3K

Revenue Growth (YoY)

AQB-100.0%

CELZ-50.0%

Forward Rev Growth

AQB0.0%

CELZ56.2%

Gross Margin (TTM)

AQB0.0%

CELZ66.7%

Operating Margin (TTM)

AQB0.0%

CELZ0.0%

EBITDA Margin (TTM)

AQB0.0%

CELZ-204213.3%

Net Margin (TTM)

AQB0.0%

CELZ-201356.7%

FCF Margin (TTM)

AQBN/A

CELZ-196726.7%

Net Income (TTM)

AQB$-18M

CELZ$-6M

FCF (TTM)

AQB$-7M

CELZ$-6M

EPS (TTM)

AQB-$3.56

CELZ-$1.63

ROE (TTM)

AQB-4002.0%

CELZ-8670.0%

ROA (TTM)

AQB-12997.0%

CELZ-8196.0%

ROIC (TTM)

AQB-2623.0%

CELZ-8670.0%

Cash

AQB$2M

CELZ$9M

Debt

AQB$0

CELZ$0

Net Cash/Debt

AQB$2M

CELZ$9M

Current Ratio (TTM)

AQB4.26x

CELZ12.91x

Quick Ratio (TTM)

AQB4.22x

CELZ12.63x

Debt/Equity (TTM)

AQB0.21x

CELZ0.00x

Debt/Assets (TTM)

AQB0.0%

CELZ0.0%

Interest Coverage (TTM)

AQBN/A

CELZN/A

Net Debt/EBITDA (TTM)

AQB0.00x

CELZ0.00x

Beta

AQB1.45

CELZ1.93

52W Performance

AQB-47.5%

CELZ-76.5%

YTD Performance

AQB10.5%

CELZ-57.4%

% from 52W High

AQB-48.5%

CELZ-86.6%

% from 52W Low

AQB35.6%

CELZ35.2%

Asset Turnover (TTM)

AQB0.01x

CELZ0.00x

FCF Yield (TTM)

AQB-132.7%

CELZ-148.5%

Earnings Yield (TTM)

AQB-339.3%

CELZ-152.0%

Dividend Yield (TTM)

AQBN/A

CELZN/A

Rule of 40

AQB-100.0

CELZ-196,776.7

EV/GP/RG

AQBN/A

CELZN/A

Ticker research

View AQB research View CELZ research

Metric	AQB AquaBounty Technologies Inc	CELZ Creative Medical Technology Holdings Inc
Market & Valuation
Market Cap	$5M	$4M
Enterprise Value	$4M	$-5M
Price	$1.05	$0.84
P/E Ratio	N/A	N/A
P/S Ratio	3.78x	1,324.83x
EV/Sales	2.28x	-1,579.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.69x	0.72x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.49x	0.80x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$3K
Revenue Growth (YoY)	-100.0%	-50.0%
Forward Rev Growth	0.0%	56.2%
Profitability
Gross Margin (TTM)	0.0%	66.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-204213.3%
Net Margin (TTM)	0.0%	-201356.7%
FCF Margin (TTM)	N/A	-196726.7%
Net Income (TTM)	$-18M	$-6M
FCF (TTM)	$-7M	$-6M
EPS (TTM)	-$3.56	-$1.63
ROE (TTM)	-4002.0%	-8670.0%
ROA (TTM)	-12997.0%	-8196.0%
ROIC (TTM)	-2623.0%	-8670.0%
Financial Health
Cash	$2M	$9M
Debt	$0	$0
Net Cash/Debt	$2M	$9M
Current Ratio (TTM)	4.26x	12.91x
Quick Ratio (TTM)	4.22x	12.63x
Debt/Equity (TTM)	0.21x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	1.93
52W Performance	-47.5%	-76.5%
YTD Performance	10.5%	-57.4%
% from 52W High	-48.5%	-86.6%
% from 52W Low	35.6%	35.2%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-132.7%	-148.5%
Earnings Yield (TTM)	-339.3%	-152.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-196,776.7
EV/GP/RG	N/A	N/A
Ticker research	View AQB research	View CELZ research